1-12 of 12
Satoshi Ito
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Role of bortezomib maintenance therapy in the anti-CD38 antibody era: Interim analysis results of a randomized Phase III study for transplant-ineligible newly diagnosed multiple myeloma (JCOG1911/B-DASH Study)

Free
Tomotaka Suzuki, Ryunosuke Machida, Yusuke Sano, Kazuyuki Shimada, Shinsuke Iida, Nobuhiko Yamauchi, Nobuhiko Nakamura, Hiroshi Handa, Yoshikazu Hori, Yasuhiro Suzuki, Daisuke Ogiya, Keisuke Kataoka, Eiji Negoro, Hiroyuki Takahashi, Junya Kuroda, Junya Makiyama, Ichiro Hanamura, Kaname Miyashita, Satoshi Ito, Hideki Uryu, Shigeru Kusumoto, Masahiro Takeuchi, Yasuhiro Harada, Takahiro Kumode, Ritsuro Suzuki, Isao Yoshida, Naoko Harada, Wataru Munakata, Hirokazu Nagai, Dai Maruyama
Journal: Blood
Blood (2025) 146 (Supplement 1): 370.
https://doi.org/10.1182/blood-2025-370
Published: 2025
Journal Articles

Home administration of isatuximab subcutaneous by on-body injector in Relapsed/Refractory multiple myeloma in the Phase 3 iraklia study

Free
María-Victoria Mateos, Silvia Ling, Claudio Cerchione, Peter Rajnics, Massimo Offidani, Fredrik Schjesvold, Masaki Ri, Satoshi Ito, Florence Suzan Teisserenc, Rick Zhang, Maya Stefanova-Urena, Sikander Ailawadhi
Journal: Blood
Blood (2025) 146 (Supplement 1): 4044.
https://doi.org/10.1182/blood-2025-4044
Published: 2025
Journal Articles

Isatuximab (Isa) subcutaneous (SC) via an on-body injector (OBI) vs isa intravenous (IV), plus pomalidomide and dexamethasone (Pd) in relapsed/refractory multiple myeloma (RRMM): East asia subgroup results from the randomized, non-inferiority, phase 3 iraklia study

Free
Xuelin Dou, Chunrui Li, Aijun Liao, Yafei Wang, Zhongjun Xia, Jing Liu, Hong Cen, Yan Xu, Fei Li, Tadao Ishida, Yuping Zhong, Satoshi Ito, Togano Tomiteru, Baijun Fang, Chunyan Sun, Hongmei Jing, Masaki Ri, Toshiyuki Kitano, Kazutaka Sunami, Chihiro Shimazaki, Shigeki Ito, Jie Jin, Rong Fu, Takuya Komeno, Kosei Matsue, Shang-Yi Huang, Sikander Ailawadhi, Florence Suzan Teisserenc, Dan Gao, Xu Wang, Yi Li, Gang Liu, Jin Lu
Journal: Blood
Blood (2025) 146 (Supplement 1): 5819.
https://doi.org/10.1182/blood-2025-5819
Published: 2025
Journal Articles

A clinical overview of infection in patients receiving elranatamab (ELRA) in combination with daratumumab (DARA) and lenalidomide (R) for newly diagnosed multiple myeloma in the MagnetisMM-6 trial

Free
Ja Min Byun, Ludek Pour, Jiri Minarik, H. Miles Prince, Elham Askari, Su-Peng Yeh, Albert Oriol, Satoshi Ito, Darrel White, Eeman Shaikh, Nina N. Green, Eric Leip, Andrea Viqueira, Hang Quach
Journal: Blood
Blood (2025) 146 (Supplement 1): 2253.
https://doi.org/10.1182/blood-2025-2253
Published: 2025
Journal Articles

Etentamig plus pomalidomide-dexamethasone combination therapy in relapsed or refractory multiple myeloma: A phase 1b dose-escalation and safety expansion study

Free
Peter Voorhees, Anita D'Souza, Hang Quach, Sabine Gaerditz, Estrella Carrillo-Cruz, Michał Mielnik, Tomasz Wrobel, Matthew Pianko, Dickran Kazandjian, M Hasib Sidiqi, Valerio De Stefano, Cesar Rodriguez Valdes, Shonali Midha, Ariel Grajales-Cruz, Hideki Goto, Satoshi Ito, Claudio Cerchione, Ziyi Jin, Shane Lee, Akshanth Polepally, Sneha Rathi, Ross La Motte-Mohs, Kristin D'Amico, Thomas Doerr, Chetasi Talati, Leanne Lash Fleming, Linda Ho, Katja Weisel, Marek Hus, Joaquin Martinez-Lopez
Journal: Blood
Blood (2025) 146 (Supplement 1): 247.
https://doi.org/10.1182/blood-2025-247
Published: 2025
Journal Articles

MagnetisMM-32: Evaluation of Elranatamab Vs EPd, PVd, or Kd in Patients with Relapsed or Refractory Multiple Myeloma and Prior Anti-CD38-Directed Therapy

Free
Steven Schuster, Satoshi Ito, Margaret Hoyle, Anne Yver, Fangxin Hong, Gregory Finn
Journal: Blood
Blood (2024) 144 (Supplement 1): 7013.
https://doi.org/10.1182/blood-2024-207377
Published: 2024
Journal Articles

Functional Validation and Clinical Significance Of a Newly Established Non-Transferrin-Bound Iron (NTBI) Assay System Utilizing Conventional Automated Analyzer

Free
Satoshi Ito, MD, Katsuya Ikuta, MD, PhD, Lynda Addo, Mayumi Hatayama, MD, Yasumichi Toki, MD, Hiroki Tanaka, PhD, Junki Inamura, MD, PhD, Motohiro Shindo, M.D., Ph.D., Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 960.
https://doi.org/10.1182/blood.V122.21.960.960
Published: 2013
Journal Articles

Increased Expression Of NGF In Hepatocytes Is An Early Event In Iron Overloaded Mouse By Transcriptome Analysis

Free
Masayo Yamamoto, MD, Hiroki Tanaka, PhD, Lynda Addo, Satoshi Ito, MD, Motohiro Shindo, M.D., Ph.D., Katsuya Ikuta, MD, PhD, Katsunori Sasaki, PHD, Takaaki Ohtake, MD, PHD, Mikihiro Fujiya, MD, PHD, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2194.
https://doi.org/10.1182/blood.V122.21.2194.2194
Published: 2013
Journal Articles

Nobel Non-Transferrin-Bound Iron (NTBI) Measuring System Utilizing Automatic Analyzer

Free
Satoshi Ito, MD, Katsuya Ikuta, MD, PhD, Katsunori Sasaki, PhD, Motohiro Shindo, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3207.
https://doi.org/10.1182/blood.V120.21.3207.3207
Published: 2012
Journal Articles

Anti-Proliferative Effect of Itraconazole On ALCL-Derived Cell Line

Free
Naoka Okamura, MD, Katsuya Ikuta, MD, PhD, Hiroki Tanaka, PhD, Lynda Addo, Yasumichi Toki, MD, Satoshi Ito, MD, Motohiro Shindo, MD, PhD, Kazuya Sato, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1367.
https://doi.org/10.1182/blood.V120.21.1367.1367
Published: 2012
Journal Articles

Direct Upregulation of Iron Regulatory Hormone Hepcidin by Interferon Alpha

Free
Kazuhiko Ichiki, MD, Katsuya Ikuta, MD, PhD, Hiroki Tanaka, PhD, Yusuke Sasaki, Yasushi Shimonaka, Katsunori Sasaki, PhD, Satoshi Ito, MD, Motohiro Shindo, MD, PhD, Takaaki Ohtake, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2103.
https://doi.org/10.1182/blood.V118.21.2103.2103
Published: 2011
Journal Articles

Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1

Free
Satoshi Ito, Parswa Ansari, Minoru Sakatsume, Harold Dickensheets, Nancy Vazquez, Raymond P. Donnelly, Andrew C. Larner, David S. Finbloom
Journal: Blood
Blood (1999) 93 (5): 1456–1463.
https://doi.org/10.1182/blood.V93.5.1456
Published: 1999